2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-N-Fmoc-L-threonine
Need Assistance?
  • US & Canada:
    +
  • UK: +

2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-N-Fmoc-L-threonine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-N-Fmoc-L-threonine is a saccharidic entity of intriguing complexity, acting as a shielded L-threonine-oligosaccharide derivative.

Category
Fmoc-Amino Acids
Catalog number
BAT-008003
CAS number
130548-92-4
Molecular Formula
C33H37NO14
Molecular Weight
671.66
2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-N-Fmoc-L-threonine
IUPAC Name
(2S,3R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxybutanoic acid
Synonyms
Fmoc-Thr(Beta-D-Glc(Ac)4)-OH; N-(9H-Fluorene-9-Ylmethoxycarbonyl)-O-(2-O,3-O,4-O,6-O-Tetraacetyl-Beta-D-Glucopyranosyl)-L-Threonine
Density
1.38±0.1 g/cm3(Predicted)
Boiling Point
777.7±60.0 °C(Predicted)
InChI
InChI=1S/C33H37NO14/c1-16(27(31(39)40)34-33(41)43-14-25-23-12-8-6-10-21(23)22-11-7-9-13-24(22)25)44-32-30(47-20(5)38)29(46-19(4)37)28(45-18(3)36)26(48-32)15-42-17(2)35/h6-13,16,25-30,32H,14-15H2,1-5H3,(H,34,41)(H,39,40)/t16-,26-,27+,28-,29+,30-,32-/m1/s1
InChI Key
PTSXZIRHPAUPGC-ZJFLVNNCSA-N
Canonical SMILES
CC(C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC4C(C(C(C(O4)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C
1. 1,5-ethano-2,3,4,5-tetrahydro-1H-3-benzazepines
L A Walter, W K Chang J Med Chem. 1975 Feb;18(2):206-8. doi: 10.1021/jm00236a022.
1,5-Ethano-2,3,4,5-tetrahydro-1H-3-benzazepine, from the LiA1H4 reduction of 2-benzyloxy-1,5-ethano-4-oxo-2,3,4,5-tetrahydro-1H-3-benzazepine, was converted to N-alkyl, aralkyl, cycloalkyl, and alkenyl derivatives which were inactive as morphine type analgetics in mice. The LiA1H4 reduction of 2-benzyloxy-1,5-etheno-4-oxo-2,3,4,5-tetrahydro-1H-3-benzazepine gave unstable products from which only the skeletally rearranged dihydro- and tetrahydrobenzo[e]isoindolines, were isolated.
2. Synthesis of 2,3,4-Trideoxy-2,3,4-trifluoroglucose
Lucas Quiquempoix, Zhong Wang, Jérôme Graton, Peter G Latchem, Mark Light, Jean-Yves Le Questel, Bruno Linclau J Org Chem. 2019 May 3;84(9):5899-5906. doi: 10.1021/acs.joc.9b00310. Epub 2019 Mar 28.
There is an increasing interest in investigating how polyfluorination of carbohydrates modifies their physical and biological properties. An example that has caught much attention is 2,3,4-trideoxy-2,3,4-trifluoroglucose. Four syntheses of this compound have been reported, which are either low yielding or long (13 or more steps). We report a 6-step synthesis of 2,3,4-trideoxy-2,3,4-trifluoroglucose starting from levoglucosan. The solution-phase structure of an intermediate, 1,6-anhydro-2,4-dideoxy-2,4-difluoroallose, features a rare example of a bifurcated F···H(O)···F hydrogen bond and is compared to its crystal structure.
3. Ring Enlargement of N-Phosphanyl-1,2,3,4-tetrahydroquinazolines
Anatoliy Marchenko, Georgyi Koidan, Anastasiia N Hurieva, Svitlana Shishkina, Eduard Rusanov, Aleksandr Kostyuk J Org Chem. 2020 Nov 20;85(22):14467-14472. doi: 10.1021/acs.joc.0c00750. Epub 2020 Sep 4.
We found that 1-phosphanyl-1,2,3,4-tetrahydroquinazolines undergo ring enlargement. Their treatment with trifluoroacetic or hydrochloric acid afforded diazaphosphepinium salts. Deprotonation of these salts gave the corresponding neutral diazaphosphepines. The reaction of 1-phosphanyl-1,2,3,4-tetrahydroquinazolines with diazomethane or phenylazide afforded triazaphosphocine derivatives via insertion of P-N moiety. At the same time, an analogous hexahydropyrimidine derivative reacted with phenylazide in a normal manner at the phosphorus atom to afford the P(V) derivative.
Online Inquiry
Verification code
Inquiry Basket